Harlan Pinto

Publications

• Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Daly ME, Le QT, Jain AK, Maxim PG, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto H, Chang DT. Head Neck. 2011; 33 (1): 103-11
• Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MJ, Fischbein NJ, Pinto H, Chang DT. Int J Radiat Oncol Biol Phys. 2010; 76 (5): 1339-46
• Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Hara W, Loo BW, Goffinet DR, Chang SD, Adler JR, Pinto HA, Fee WE, Kaplan MJ, Fischbein NJ, Le QT. Int J Radiat Oncol Biol Phys. 2008; 71 (2): 393-400
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. J Natl Cancer Inst. 2008; 100 (4): 261-9
• In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Le QT, Koong A, Lieskovsky YY, Narasimhan B, Graves E, Pinto H, Brown JM, Spielman D. Int J Radiat Oncol Biol Phys. 2008; 71 (4): 1151-7
• Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ. J Nucl Med. 2007: 48 Suppl 1 58S-67S
• Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Head Neck. 2007; 29 (3): 211-20
• Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Shirazi HA, Sivanandan R, Goode R, Fee WE, Kaplan MJ, Pinto HA, Goffinet DR, Le QT. Head Neck. 2006; 28 (7): 587-94
• Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas. Le QT, Taira A, Budenz S, Jo Dorie M, Goffinet DR, Fee WE, Goode R, Bloch D, Koong A, Martin Brown J, Pinto HA. Cancer. 2006; 106 (9): 1940-9
• Plasma osteopontin is an independent prognostic marker for head and neck cancers. Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. J Clin Oncol. 2006; 24 (33): 5291-7
• Positron-emission tomography for surveillance of head and neck cancer. Ryan WR, Fee WE, Le QT, Pinto HA. Laryngoscope. 2005; 115 (4): 645-50
• Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Sivanandan R, Kaplan MJ, Lee KJ, Lebl D, Pinto H, Le QT, Goffinet DR, Fee WE. Arch Otolaryngol Head Neck Surg. 2004; 130 (12): 1369-73
• Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Int J Radiat Oncol Biol Phys. 2004; 60 (1): 171-7
• Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Le QT, Kovacs MS, Dorie MJ, Koong A, Terris DJ, Pinto HA, Goffinet DR, Nowels K, Bloch D, Brown JM. Int J Radiat Oncol Biol Phys. 2003; 56 (2): 375-83
• Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ. Clin Cancer Res. 2003; 9 (1): 59-67
• Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, Pinto HA, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2003; 56 (4): 1046-54
• Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay. Terris DJ, Ho EY, Ibrahim HZ, Dorie MJ, Kovacs MS, Le QT, Koong AC, Pinto HA, Brown JM. Arch Otolaryngol Head Neck Surg. 2002; 128 (6): 698-702
• In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. Star-Lack JM, Adalsteinsson E, Adam MF, Terris DJ, Pinto HA, Brown JM, Spielman DM. AJNR Am J Neuroradiol. 2000; 21 (1): 183-93
• DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. Dorie MJ, Kovacs MS, Gabalski EC, Adam M, Le QT, Bloch DA, Pinto HA, Terris DJ, Brown JM. Neoplasia. 1999; 1 (5): 461-7
• Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE, Pinto H, Goffinet DR. Int J Radiat Oncol Biol Phys. 1999; 45 (4): 915-21
• Tissue oxygen distribution in head and neck cancer patients. Adam MF, Gabalski EC, Bloch DA, Oehlert JW, Brown JM, Elsaid AA, Pinto HA, Terris DJ. Head Neck. 1999; 21 (2): 146-53
• Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Dagum P, Pinto HA, Newman JP, Higgins JP, Terris DJ, Goffinet DR, Fee WE. Am J Surg. 1998; 176 (5): 448-52
• Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers. Gabalski EC, Adam M, Pinto H, Brown JM, Bloch DA, Terris DJ. Laryngoscope. 1998; 108 (12): 1856-60
• Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Newman JP, Terris DJ, Pinto HA, Fee WE, Goode RL, Goffinet DR. Ann Otol Rhinol Laryngol. 1997; 106 (2): 117-22
• Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Jacobs C, Pinto H. Semin Oncol. 1995; 22 (6): 540-52
• Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy. Pinto HA, Jacobs C. Cancer Treat Res. 1995: 74 243-62
• Head and neck cancer - combined modality therapy and chemotherapy. Pinto HA, Jacobs C.. : Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncology. Mosby, St. Louis. 1995
• Head and neck cancers. Jacobs C, Pinto HA.. Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutics Third Edition. J.B. Lippincott, Philadelphia. 1995: 162-169.
• Chemotherapy for recurrent and metastatic head and neck cancer. Pinto HA, Jacobs C. Hematol Oncol Clin North Am. 1991; 5 (4): 667-86